"label","description","instanceType","id","uuid:ID","name","text"
"","Main objective","Objective","Objective_1","dc18f6a2-fcbe-4f0f-8637-457ec931bd17","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"","Safety","Objective","Objective_2","e0822731-17d9-4164-859f-d4cedf2259c5","OBJ2","To document the safety profile of the xanomeline TTS."
"","Behaviour","Objective","Objective_3","4ed82e64-c764-4bb7-b368-606089d5e499","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
